Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Jansen

Showing results (81-90 of 254) with videos related to

Pageof 26
Sort By:
Human Vaccines & Immunotherapeutics|September 15, 2018
The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgeryA Gurtman, E Begier, N Mohamed, et al.
Microbiology and Molecular Biology Reviews : MMBR|May 24, 2013
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseLisa K McNeil, Robert J Zagursky, Shuo L Lin, et al.
Human Vaccines|January 20, 2011
Challenges for the evaluation of Staphylococcus aureus protein based vaccines: monitoring antigenic diversityEllen Murphy, Shuo L Lin, Lorna Nunez, et al.
Vaccine|September 6, 2021
Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 yearsJody Lawrence, Nicholas Kitchin, Annaliesa S Anderson, et al.
Vaccine|November 29, 2021
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccinationKevin Cannon, Charles Elder, Mariano Young, et al.
Frontiers in Cell and Developmental Biology|June 17, 2026
Hnrnpa1 is essential for early zebrafish development and lipid metabolism: insights from a novel zebrafish knockout modelLara U Jansen, Özge P Burhan, Alexander Hruscha, et al.
Human Vaccines|January 20, 2011
Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C DiseaseShannon L Harris, Duzhang Zhu, Ellen Murphy, et al.
The Journal of Biological Chemistry|February 20, 1999
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytesJ G Joyce, J S Tung, C T Przysiecki, et al.
Plos One|July 7, 2015
Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B VaccinesEduardo Rojas, Johanna Hoyos, Neil J Oldfield, et al.
Vaccine|January 28, 2020
Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)Julie A Bettinger, Paul Liberator, Scott A Halperin, et al.
Pageof 26

Showing results (81-90 of 254) with videos related to

Sort By:
Pageof 26
Human Vaccines & Immunotherapeutics|September 15, 2018
The development of a staphylococcus aureus four antigen vaccine for use prior to elective orthopedic surgeryA Gurtman, E Begier, N Mohamed, et al.
Microbiology and Molecular Biology Reviews : MMBR|May 24, 2013
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseLisa K McNeil, Robert J Zagursky, Shuo L Lin, et al.
Human Vaccines|January 20, 2011
Challenges for the evaluation of Staphylococcus aureus protein based vaccines: monitoring antigenic diversityEllen Murphy, Shuo L Lin, Lorna Nunez, et al.
Vaccine|September 6, 2021
Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 yearsJody Lawrence, Nicholas Kitchin, Annaliesa S Anderson, et al.
Vaccine|November 29, 2021
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccinationKevin Cannon, Charles Elder, Mariano Young, et al.
Frontiers in Cell and Developmental Biology|June 17, 2026
Hnrnpa1 is essential for early zebrafish development and lipid metabolism: insights from a novel zebrafish knockout modelLara U Jansen, Özge P Burhan, Alexander Hruscha, et al.
Human Vaccines|January 20, 2011
Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis Serogroup C DiseaseShannon L Harris, Duzhang Zhu, Ellen Murphy, et al.
The Journal of Biological Chemistry|February 20, 1999
The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytesJ G Joyce, J S Tung, C T Przysiecki, et al.
Plos One|July 7, 2015
Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B VaccinesEduardo Rojas, Johanna Hoyos, Neil J Oldfield, et al.
Vaccine|January 28, 2020
Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)Julie A Bettinger, Paul Liberator, Scott A Halperin, et al.
Pageof 26